Stroke Treatment - Novastem

Stroke Treatment.

How do stem cells allow regenerative mechanisms to thrive?

Stroke is a medical condition that can be caused by a blood clot in the brain (ischemic) or by bleeding (hemorrhagic) which causes inflammation and eventually alterations to the blood flow to the damaged tissue, resulting in the presence of symptoms that can lead to a permanent state of disability. According to the CDC, strokes are the fifth cause of death in the United States and one of the leading conditions with permanent disabilities in the world. High blood pressure is considered a main risk factor for stroke, including the presence of other diseases such as diabetes or atherosclerosis.

One of the crucial and most important factor in a stroke is the prompt diagnosis. This starts with the people surrounding the patient and the paramedics, by evaluating the symptoms of the patient, which often are:

  • Trouble with speech or understanding.
  • Numbness or paralysis in one side of the face and body.
  • Confusion.
  • Intense headache (seen more commonly in hemorrhagic).
  • Loss of vision in one side.

One the patient arrives to a specialized center, confirmation with an image study to determine which type of event the patient is going through, because one treatment is not indicated for the other type. You cannot give blood thinners to an hemorrhagic stroke because in result you will have more bleeding. However, the medical team must determine the diagnosis using everything in their resources to improve the outcome of the patients.

Stroke can be caused by many factors including:
  • High Blood Pressure.
  • Atherosclerosis.
  • Diabetes.
  • Smokers.
  • Mesenchymal stem cells have properties that aid the body with the healing process. They are considered immunomodulators that may migrate to a lesion site to produce a down regulation of the acute inflammatory response in order to promote the healing and regenerative mechanisms involved in our body. They secrete growth factors that promote healing including factors that produce new blood vessels to increase blood flow to damaged tissue.

    Application Type:

    Our administration route is an Intravenous application of mesenchymal stem cells.